Cellid, COVID-19 vaccine Korean stockBullish Reasons - Cup & handle formation - Bounces on trendline - Currently developing COVID-19 vaccine in Korea alongside other biotech products - Korean government granted $30 mil to develop vaccines recently2by CaprisonUpdated 0